Sinead Toomey
0000-0002-1365-8173
4 papers found
Refreshing results…
Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer
Effects of HER family-targeting tyrosine kinase inhibitors on antibody-dependent cell-mediated cytotoxicity in HER2-expressing breast cancer
Design, synthesis and evaluation of novel 2,2-dimethyl-2,3-dihydroquinolin-4(1H)-one based chalcones as cytotoxic agents
Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies
Missing publications? Search for publications with a matching author name.